Research Article
15-Lipoxygenase-1 Is Involved in the Effects of Atorvastatin on Endothelial Dysfunction
Table 3
Numbers in results.
| | Figure 3 | Group | Mean ± SD |
| | (b) | Lv-shALOX15 | 0.577 ± 0.111 |
| | (c) | Lv-shALOX15 | 1.315 ± 0.215 |
| | (d) | Lv-ALOX15 | 1.380 ± 0.097 |
| | (e) | Lv-ALOX15 | 3.192 ± 0.336 |
| | (f) p-AKT | ox-LDL | 0.441 ± 0.112 | | ox-LDL + Ator | 0.981 ± 0.163 | | ox-LDL + Ator + Lv-ALOX15 | 0.365 ± 0.041 |
| | (f) p-eNOS | ox-LDL | 0.591 ± 0.155 | | ox-LDL + Ator | 0.809 ± 0.032 | | ox-LDL + Ator + Lv-shALOX15 | 0.994 ± 0.084 |
| | (g) VCAM-1 | ox-LDL | 1.635 ± 0.239 | | ox-LDL + Ator + Lv-ALOX15 | 2.206 ± 0.633 |
| | (g) ICAM-1 | ox-LDL | 1.435 ± 0.152 | | ox-LDL + Ator | 0.740 ± 0.111 | | ox-LDL + Ator + Lv-ALOX15 | 1.553 ± 0.089 |
|
|
